INDIANAPOLIS
印第安納波利斯
,
，
Aug. 22, 2025
2025年8月22日
/PRNewswire/ --
/PRNewswire/ --
Eli Lilly and Company
禮來公司
(NYSE:LLY) will participate in the Wells Fargo 20th Annual Healthcare Conference on
(NYSE:LLY) 將參加富國銀行第20屆年度醫療保健會議，
Sept. 5, 2025
2025年9月5日
.
。
Patrik Jonsson
帕特里克·約翰松
, executive vice president and president of
，執行副總裁兼總裁
Lilly International
禮來國際
, will take part in a fireside chat at
，將參加一場爐邊談話 tại
9:30 a.m., Eastern time
上午9點30分，東部時間
.
。
A live audio webcast will be available on the 'Webcasts & Presentations' section of Lilly's investor website at
現場音頻網絡直播將在禮來公司投資者網站的“網絡直播與演講”部分提供。
https://investor.lilly.com/webcasts-and-presentations
https://investor.lilly.com/webcasts-and-presentations
. A replay of the presentation will be available on this same website for approximately 90 days.
演示文稿的重播將在同一網站上提供大約 90 天。
About Lilly
關於禮來公司
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases.
禮來是一家醫藥公司，將科學轉化爲治療手段，以改善世界各地人們的生活。近150年來，我們一直在開創改變生命的發現，如今我們的藥物幫助了全球數千萬人。通過利用生物技術、化學和基因藥物的力量，我們的科學家正在加速推進新的發現，以解決一些全球最重要的健康挑戰：重新定義糖尿病護理；治療肥胖症並遏制其最具破壞性的長期影響；推動對抗阿爾茨海默病的鬥爭；爲一些最令人衰弱的免疫系統疾病提供解決方案；並將最難治療的癌症轉變爲可管理的疾病。
With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit .
每朝着更健康的世界邁出一步，我們都受到一個目標的激勵：讓數百萬人的生活更美好。這包括開展反映世界多樣性的創新臨牀試驗，並努力確保我們的藥品可及且價格合理。欲瞭解更多信息，請訪問。
Lilly.com
Lilly.com
and
和
Lilly.com/news
Lilly.com/新聞
, or follow us on
，或者關注我們
,
，
, and
，以及
領英
. F-LLY
. F-LLY
Trademarks and
商標和
Trade Names
商標名稱
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto.
本新聞稿中提到的所有商標或商號均爲公司財產，或者，如果引用了屬於其他公司的商標或商號，則爲各自所有者的財產。僅爲方便起見，本新聞稿中提及的商標和商號未附帶®和™符號，但此類引用不應被解釋爲表示公司或在適用範圍內其各自所有者不會根據適用法律全力主張公司或其對該等權利的所有權。
We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies..
我們無意使用或展示其他公司的商標和商號，以暗示我們與其他公司存在關聯，或得到其認可或贊助。
Refer to:
參考：
Ashley Hennessey
阿什利·亨尼西
;
；
gentry_ashley_jo@lilly.com
gentry_ashley_jo@lilly.com
; 317-416-4363 (Media)
；317-416-4363（媒體）
Michael Czapar;
邁克爾·查帕爾；
czapar_michael_c@lilly.com
czapar_michael_c@lilly.com
; 317-617-0983 (Investors)
；317-617-0983（投資者）
View original content to download multimedia:
查看原始內容以下載多媒體：
https://www.prnewswire.com/news-releases/lilly-to-participate-in-wells-fargo-20th-annual-healthcare-conference-302536339.html
https://www.prnewswire.com/news-releases/禮來將參加富國銀行第20屆年度醫療保健會議-302536339.html
SOURCE
源代碼
Eli Lilly and Company
禮來公司